22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 09, 2023 06:00 ET
|
22nd Century Group, Inc
Accelerates VLN® Launch with Key National Distribution AgreementsLaunching VLN® in Texas, California and Florida with New National Scale Distributor and Retail PartnersScaling Hemp/Cannabis Revenue...
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
January 24, 2023 09:20 ET
|
22nd Century Group, Inc
Immediately Accretive Addition to the Hemp/Cannabis Business with Positive EBITDA 1,276 Novel Food Applications for Cannabinoid Products to Accelerate Growth in the U.K. and EU Food and...
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
January 23, 2023 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group (Nasdaq: XXII) to Ring the Nasdaq Stock Market Closing Bell
August 22, 2022 09:30 ET
|
22nd Century Group, Inc
Celebrates the Launch and Accelerated Expansion of VLN®, the Only Combustible Cigarettes Authorized by the FDA That “Helps You Smoke Less” VLN® 95% Less Nicotine Cigarette Pilot in Chicago Exceeded...
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
April 11, 2022 09:25 ET
|
22nd Century Group, Inc
Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
March 28, 2022 09:28 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., March 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s...
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
March 09, 2022 09:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
March 01, 2022 06:00 ET
|
22nd Century Group, Inc
Secured FDA MRTP Authorization for VLN® King and VLN® Menthol King Reduced Nicotine Content CigarettesAdvancing to U.S. Pilot Market Launch in ChicagoAnnounced Circle K as First VLN® Retail Trade...
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
February 23, 2022 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Secures USDA Organic Certification for Needle Rock Farms
February 10, 2022 11:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...